MissionIR Articles
-
AnPac Bio-Medical Science Co. Ltd. (NASDAQ: ANPC) Files for National Medical Products Administration Registration of Early-Warning Cancer Technology with a Record 11 Tumor Types Under Formal Medical Device Product Registration
AnPac Bio-Medical Science Co., Ltd. has developed its proprietary Cancer Differentiation Analysis (“CDA”) technology to detect biophysical signals as an alternative early disease indicator to blood-based biomarker testing for cancer The company has laboratories and…
-
Flora Growth Corp. (NASDAQ: FLGC) Expands Across International Borders into Europe and Asia
Flora Growth business divisions include pharmaceuticals, cosmetics, hemp textiles, and food & beverage sectors Flora Lab now has three GMP certifications – one each for cosmetics, phytotherapeutic products, and dietary supplements Flora Growth operates internationally…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Enters Definitive Agreement for ‘Transformative’ Acquisition of Leading Manufacturer of Rare Cannabinoids
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, has signed a definitive agreement to acquire BayMedica Inc., a private, U.S.-based company that specializes in the manufacturing and commercialization…
-
MissionIRNewsBreaks – FingerMotion Inc. (FNGR) Maintains Investor Relations Momentum Throughout 2021
FingerMotion (OTCQX: FNGR) has always made it a point to communicate all developments within the company. “The first press release of the year was OTC Market Group Inc.’s announcement that FingerMotion had qualified to trade…
-
MissionIRNewsBreaks – Infobird Software Co. Ltd. (NASDAQ: IFBD) Asserting Position as a Leader in Chinese, Global SaaS Markets
Infobird (NASDAQ: IFBD), a business-to-business (“B2B”) artificial intelligence (“AI”) solutions company, is positioning itself to make the most out of the expanding software-as-a-service (“SaaS”) market, which is expected to grow by $99.99 billion between 2021…
-
MissionIRNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) to Present at H.C. Wainwright 23rd Annual Global Investment Conference
InMed Pharmaceuticals (NASDAQ: INM), a leader in the manufacturing and clinical development of rare cannabinoids, today announced that its president and CEO Eric. A. Adams will present at the H.C. Wainwright 23rd Annual Global Investment…
-
Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Marks Impressive Performance for Q2 2021
$58.5 million in Adjusted Sales for first six months of 2021 The company also reported repaying approximately $18 million of debt and restructuring over $20 million into a long-term debt Q2 also marked RWB’s acquisition…
-
PlantX Life Inc. (CSE: VEGA) (Frankfurt: WNT1) (OTCQB: PLTXF) Strengthens its Board with Fred Leigh’s Appointment as Executive Chairman
On September 7, 2021, Mr. Fred Leigh was appointed as director and Executive Chairman of PlantX’s Board of Directors, effective immediately Mr. Leigh previously chaired the company’s Advisory Board, which has since been dissolved PlantX…
-
MissionIRNewsBreaks – Energy Fuels Inc. (NYSE American: UUUU) (TSX: EFR) Playing Essential Role in US Efforts to End Dependence on China for REEs
Energy Fuels (NYSE American: UUUU) (TSX: EFR) may be the only company outside of China with the equipment, expertise and licenses in place to responsibly process monazite, one of the most valuable rare earth elements…
-
MissionIRNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Announces Receipt of GMC Authorization Permitting Cosmetic Product Manufacturing
Flora Growth (NASDAQ: FLGC), a leading all-outdoor cultivator and manufacturer of global cannabis products and brands, announced that it has received Good Manufacturing Practices (“GMP”) certification from the Colombian National Food and Drug Surveillance Institute…
-
MissionIRNewsBreaks – Kaival Brands Innovations Group Inc.’s (NASDAQ: KAVL) Manufacturing Partner Moves to Final Phase of Regulatory Authorization
Kaival Brands (NASDAQ: KAVL), a company focused on developing products into mature, dominant brands, is the exclusive global distributor of a portfolio of premium vape products manufactured by Bidi(R) Vapor LLC. Notably, the Bidi(R) Stick…
-
MissionIRNewsBreaks – PlantX Life Inc. (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) Announces Intention to Commence NCIB to Repurchase up to 5% of Its Common Shares
PlantX Life (CSE: VEGA) (OTCQB: PLTXF) (Frankfurt: WNT1) today announced its intention to commence a normal course issuer bid (“NCIB”), under which the company may purchase up to 6,071,757 of its common shares, representing approximately 5%…
-
MissionIRNewsBreaks – The Alkaline Water Company Inc. (NASDAQ: WTER) (CSE: WTER) Announced as Participant at H.C. Wainwright Global Investment Conference
The Alkaline Water Company (NASDAQ: WTER) (CSE: WTER), the country’s largest independent alkaline water company, will be featured at this year’s 23rd annual H.C. Wainwright Global Investment Conference. The three-day, virtual conference is scheduled for Sept.…
-
MissionIRNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Builds Out New Florida Facility for Edibles Production
Red White & Bloom (CSE: RWB) (OTCQX: RWBYF), a leading provider of cannabis brands in the United States, announced that it has built-out a new production facility. The facility meets GMP specifications and enables the…
-
Data Services Innovator FingerMotion Inc. (FNGR) Sees Growing Potential in China’s Insurance Market
U.S.-based data tech company FingerMotion is focused on the market potential of Chinese companies’ need for rich communication services (“RCS”) and big-data insights FingerMotion has been particularly focused on the insurance industry’s need for data…
-
MissionIRNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) to Present at H.C. Wainwright 23rd Annual Global Investment Conference
Lexaria Bioscience Corp. (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its CEO and Chairman Chris Bunka will present at the 23rd Annual H.C. Wainwright Global Investment Conference. The event…
-
Flora Growth Corp. (NASDAQ: FLGC) Inks €2M Investment in Hoshi As Part of its European Expansion Plan
Flora closed a €2 million investment in Hoshi International Inc., fulfilling the earlier-announced LOI back in June 2021 This move is set to capitalize on Hoshi’s strong European presence, its technical know-how along with its…
-
MissionIRNewsBreaks – Cybin Inc. (NEO: CYBN) (NYSE American: CYBN) CEO to Present Virtually at H.C. Wainwright 23rd Annual Global Investment Conference
Cybin (NEO: CYBN) (NYSE American: CYBN), a life sciences company focused on advancing psychedelic pharmaceutical therapeutics for various psychiatric and neurological conditions, today announced that on Monday, September 13, 2021, Chief Executive Officer Doug Drysdale…
-
Lexaria Bioscience Corp. (NASDAQ: LEXX) to Address Advances in its Bioavailability Technology DehydraTECH(TM) at Wainwright Life Sciences Conference
Drug delivery technology innovator Lexaria Bioscience is celebrating the positive outcomes of clinical testing of its trademarked DehydraTECH platform for reducing the blood stream delivery time of anti-virals, NSAIDS and potential hypertension treatments Lexaria will…
-
MissionIRNewsBreaks — Save Foods Inc. (NASDAQ: SVFD) Receives Patent for Proprietary Compound from European Office
Save Foods (NASDAQ: SVFD), an agri-food-tech company focused on developing and selling eco-friendly products specifically designed to extend the shelf life and ensure food safety of fresh fruits and vegetables, announced that the European patent…
Search Articles
Latest Articles
- A2Z Cust2Mate Solutions Corp. (NASDAQ: AZ) Advancing Retail Innovation Through AI-Powered Smart-Cart Technology
- Forward Industries Inc. (NASDAQ: FWDI) Positive Update for Shareholders After Debuting the Company’s Solana Treasury Strategy
- Ucore Rare Metals Inc. (TSX.V: UCU) (OTCQX: UURAF) Secures Funding to Strengthen North American Supply Chain
- MissionIRNewsBreaks – Soligenix Inc. (NASDAQ: SNGX) Featured in BioMedWire Editorial on Rare Disease Therapies
- MissionIRNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Talks Bold Strategy to Treat GBM in BioMedWire Podcast